REGN
NEGATIVE BIASRegeneron Pharmaceuticals, Inc. · Healthcare
$756.85-1.43%LAST CLOSE
24H-1.43%
1W-0.66%
1M-2.30%
1Y+36.67%
Live Chart · REGN
1DNY TIME
BOGA Master Score
45.6
High conviction score
BOGA AI Model Projection
Strategic Observation Zone$753.07 - $760.63
Projected Growth Objective$798.13 - $855.14
Model Invalidation Level$682.55 - $718.47
Risk/Reward1.5:1
AD-S2 · 300×250 Sidebar
Technical Indicators
RSI (14)
48.5
Neutral
MACD
1.951
NEUTRAL
RVOL
0.79x
Normal
Trends
DOWN
UP
EMA Stack
Bearish
STABLE
BB Squeeze
HIGH
MONITOR
Fundamentals & Margins
Market Cap
P/E Ratio
vs Sector: 25.0730915
FCF Yield
Gross Margin
Operating Margin
Net Margin
Sector Context
Benchmarked against
XLV
5D Performance
+1.3%
REGN is currently ranked in the top 20% of its sector based on BOGA Master Scores. It has outperformed XLV by 4.2% over the last 30 trading days.
Insider Activity (90D)
| Transaction | Shares | Net Direction |
|---|---|---|
| Buys | 0 | SELL |
| Sells | 5 |
Last Transaction: SELL 100 shares

Share This Insight
Help others discover this score. Professional analysts share high-conviction data.
Share This Insight
Help others discover this score. Professional analysts share high-conviction data.